Compounds > mannitol
Page last updated: 2024-08-17

mannitol and Multiple Myeloma

mannitol has been researched along with Multiple Myeloma in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19902 (40.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's1 (20.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Aagaard, TG; Ahmad, SM; Andersen, MH; Breinholt, MF; Do, TH; Grauslund, JH; Hansen, M; Helleberg, C; Jørgensen, NG; Klausen, TW; Klausen, U; Knudsen, LM; Martinenaite, E; Met, Ö; Olsen, LR; Svane, IM1
Antunes, E; Davis, HL; de Boer, K; Greenberg, PD; Heit, W; Hol, S; Kuball, J; Lotz, C; Theobald, M; van Dorp, S; Vicari, AP; Wagner, E; Wattad, M; Weeratna, RD1
Elisseeva, OA; Fujiki, F; Fukuda, Y; Hosen, N; Kawakami, M; Kawase, I; Kito, K; Morita, S; Nakajima, H; Nishida, S; Ogata, A; Ohno, S; Oji, Y; Oka, Y; Sakamoto, J; Shirakata, T; Sugiyama, H; Tsuboi, A; Udaka, K; Yasukawa, M; Yoshihara, S1
Berkseth, RO; Kjellstrand, CM1
Luke, RG1

Reviews

2 review(s) available for mannitol and Multiple Myeloma

ArticleYear
Radiologic contrast-induced nephropathy.
    The Medical clinics of North America, 1984, Volume: 68, Issue:2

    Topics: Absorption; Acute Kidney Injury; Adult; Contrast Media; Creatinine; Dehydration; Diabetes Complications; Humans; Ischemia; Kidney; Kidney Tubules; Mannitol; Middle Aged; Multiple Myeloma; Risk; United States; Urography

1984
Diagnostic possibilities in acute renal failure.
    Geriatrics, 1976, Volume: 31, Issue:8

    Topics: Acute Kidney Injury; Blood Circulation; Blood Urea Nitrogen; Blood Volume; Extracellular Space; Furosemide; Glomerulonephritis; Humans; Hypertension, Malignant; Ischemia; Kidney; Liver Diseases; Mannitol; Multiple Myeloma; Nephritis; Osmolar Concentration; Ureteral Obstruction

1976

Trials

2 trial(s) available for mannitol and Multiple Myeloma

ArticleYear
Peptide Vaccination Against PD-L1 With IO103 a Novel Immune Modulatory Vaccine in Multiple Myeloma: A Phase I First-in-Human Trial.
    Frontiers in immunology, 2020, Volume: 11

    Topics: Adult; Aged; B7-H1 Antigen; Cancer Vaccines; Female; Humans; Male; Mannitol; Middle Aged; Multiple Myeloma; Neoplasm Proteins; Oleic Acids; Peptides; Vaccines, Subunit

2020
Pitfalls of vaccinations with WT1-, Proteinase3- and MUC1-derived peptides in combination with MontanideISA51 and CpG7909.
    Cancer immunology, immunotherapy : CII, 2011, Volume: 60, Issue:2

    Topics: Adolescent; Antigens, Neoplasm; Cancer Vaccines; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Female; Humans; Leukemia, Myeloid, Acute; Male; Mannitol; Mucin-1; Multiple Myeloma; Myeloblastin; Neoplasm Staging; Neoplasm, Residual; Oleic Acids; Oligodeoxyribonucleotides; Peptides; Pilot Projects; Treatment Outcome; WT1 Proteins

2011

Other Studies

1 other study(ies) available for mannitol and Multiple Myeloma

ArticleYear
Wilms tumor gene WT1 peptide-based immunotherapy induced a minimal response in a patient with advanced therapy-resistant multiple myeloma.
    International journal of hematology, 2007, Volume: 86, Issue:5

    Topics: Bone Marrow; Cancer Vaccines; CD8-Positive T-Lymphocytes; Chemokine CXCL12; Drug Resistance, Neoplasm; Female; HLA-A Antigens; HLA-A24 Antigen; Humans; Lymphocyte Count; Lysosomal-Associated Membrane Protein 1; Lysosomal-Associated Membrane Protein 2; Mannitol; Middle Aged; Multiple Myeloma; Myeloma Proteins; Oleic Acids; Radionuclide Imaging; Receptors, CXCR4; Remission Induction; Time Factors; Vaccination; WT1 Proteins

2007